- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources5
- Resource Type
-
0000000005000000
- More
- Availability
-
50
- Author / Contributor
- Filter by Author / Creator
-
-
Alford, Rebecca F. (1)
-
Azouz, Laura R. (1)
-
Barry, Cornelius S. (1)
-
Bedewitz, Matthew A. (1)
-
Black, Douglas L. (1)
-
Cao, Qin (1)
-
Chan, Henry (1)
-
Dolan, Erin L. (1)
-
Drake, Justin M. (1)
-
Dubois, Bethany (1)
-
Eisenberg, David S. (1)
-
Feigon, Juli (1)
-
Gonzales, Lynda (1)
-
Gray, Jeffrey J. (1)
-
Haussler, David (1)
-
Jiang, Lin (1)
-
Khare, Sagar D. (1)
-
Klesmith, Justin R. (1)
-
Leaver-Fay, Andrew (1)
-
Li, Binsen (1)
-
- Filter by Editor
-
-
& Spizer, S. M. (0)
-
& . Spizer, S. (0)
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Bosch, N. (0)
-
& Brennan K. (0)
-
& Brennan, K. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Drown, S. (0)
-
& Ferretti, F. (0)
-
& Higgins, A. (0)
-
& J. Peters (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& S. Spitzer (0)
-
& Sahin. I. (0)
-
& Spitzer, S. (0)
-
& Spitzer, S.M. (0)
-
(submitted - in Review for IEEE ICASSP-2024) (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Significance Proteins have shown promise as therapeutics and diagnostics, but their effectiveness is limited by our inability to spatially target their activity. To overcome this limitation, we developed a computationally guided method to design inactive proenzymes or zymogens, which are activated through cleavage by a protease. Since proteases are differentially expressed in various tissues and disease states, including cancer, these proenzymes could be targeted to the desired microenvironment. We tested our method on the therapeutically relevant protein carboxypeptidase G2 (CPG2). We designed Pro-CPG2s that are inhibited by 80 to 98% and are partially to fully reactivatable following protease treatment. The developed methodology, with further refinements, could pave the way for routinely designing protease-activated protein-based therapeutics and diagnostics that act in a spatially controlled manner.more » « less
-
Wrenbeck, Emily E.; Bedewitz, Matthew A.; Klesmith, Justin R.; Noshin, Syeda; Barry, Cornelius S.; Whitehead, Timothy A. (, ACS Synthetic Biology)
-
Cao, Qin; Shin, Woo Shik; Chan, Henry; Vuong, Celine K.; Dubois, Bethany; Li, Binsen; Murray, Kevin A.; Sawaya, Michael R.; Feigon, Juli; Black, Douglas L.; et al (, Nature Chemistry)
-
Toor, Jugmohit S.; Rao, Arjun A.; McShan, Andrew C.; Yarmarkovich, Mark; Nerli, Santrupti; Yamaguchi, Karissa; Madejska, Ada A.; Nguyen, Son; Tripathi, Sarvind; Maris, John M.; et al (, Frontiers in Immunology)
-
Alford, Rebecca F.; Leaver-Fay, Andrew; Gonzales, Lynda; Dolan, Erin L.; Gray, Jeffrey J. (, PLOS Computational Biology)
An official website of the United States government
